This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savin, C.
Right arrow Articles by Derouin, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savin, C.
Right arrow Articles by Derouin, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2008, p. 2590-2594, Vol. 46, No. 8
0095-1137/08/$08.00+0     doi:10.1128/JCM.00226-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Assessment of Cryptodiag for Diagnosis of Cryptosporidiosis and Genotyping Cryptosporidium Species{triangledown}

C. Savin,1 C. Sarfati,2,3 J. Menotti,2,3 J. Jaouhari,1 S. Wurtzer,1 Y. J. F. Garin,2,3 and F. Derouin2,3*

Bio Advance, Espace Villa Parc, L'Érable, 1 avenue Marne et Gondoire, 77600 Bussy Saint Martin, France,1 Laboratoire de Parasitologie-Mycologie, Faculté de Médecine Denis Diderot, Université Paris 7, 16 rue Henri Huchard, 75018 Paris, France,2 Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France3

Received 4 February 2008/ Returned for modification 10 April 2008/ Accepted 2 June 2008

The performance of a new commercial PCR-enzyme-linked immunosorbent assay (ELISA) (Cryptodiag; Bio Advance, France) for the diagnosis of cryptosporidiosis and the identification of Cryptosporidium hominis and C. parvum from stool samples was examined. This test is based on PCR amplification of Cryptosporidium DNA extracted from stools, followed by an ELISA based on hybridization with Cryptosporidium sp.-, C. hominis-, or C. parvum-specific probes. In spiking experiments, approximately five oocysts were detected either in water or in stool suspensions while assessing for the efficient removal of stool PCR inhibitors. No cross-reactivity was observed in the detection of C. parvum and C. hominis using the respective specific probes. Thirty-three fecal samples from patients with microscopically proven cryptosporidiosis and 118 from patients with or without other digestive protozoan infections were tested by Cryptodiag, blinded to the results of microscopy. Compared to microscopy, the sensitivity of Cryptodiag was 97.0% (32/33) and 100% (33/33), including the gray zone, and specificity was 98.3% (116/118) and 96.6% (114/118), including the gray zone. Among 34 positive results, Cryptodiag identified 19 due to C. hominis, 8 due to C. parvum, and 7 due to Cryptosporidium spp. Genotyping by Cryptodiag agreed with reference typing methods in 85% of cases of C. parvum or C. hominis infections. Cryptodiag proved to be reliable and sensitive for the diagnosis of cryptosporidiosis. The use of specific probes allowed the identification of C. hominis and C. parvum, i.e., the two main species responsible for human cryptosporidiosis, and rapidly provided information on the possible source of infection.

* Corresponding author. Mailing address: Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France. Phone: 33 1 42 49 95 03. Fax: 33 1 42 49 48 03. E-mail: francis.derouin{at}sls.aphp.fr

{triangledown} Published ahead of print on 25 June 2008.

Journal of Clinical Microbiology, August 2008, p. 2590-2594, Vol. 46, No. 8
0095-1137/08/$08.00+0     doi:10.1128/JCM.00226-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»